Q1 2024 · 13F-HR
Blue Water Life Science Advisors, LPholdings as filed
Filed 2024-05-15 · accession 0001172661-24-002531
$106.3M
Reported value
8
Positions
2024-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 632307104 | NTRA | NATERA INC | $46.0M | 43.3% | 503,094 | Common | SOLE |
| 00974H104 | — | AKOYA BIOSCIENCES INC | $22.0M | 20.7% | 4,697,785 | Common | SOLE |
| 40131M109 | GH | GUARDANT HEALTH INC | $11.8M | 11.1% | 571,047 | Common | SOLE |
| 88025U109 | TXG | 10X GENOMICS INC | $7.3M | 6.87% | 194,500 | Common | SOLE |
| 74766Q101 | QTRX | QUANTERIX CORP | $7.3M | 6.85% | 309,093 | Common | SOLE |
| 00650F109 | ADPT | ADAPTIVE BIOTECHNOLOGIES COR | $5.4M | 5.10% | 1,687,665 | Common | SOLE |
| 30063P105 | EXK | EXACT SCIENCES CORP | $4.0M | 3.72% | 57,343 | Common | SOLE |
| 57777K106 | MXCT | MAXCYTE INC | $2.5M | 2.38% | 603,937 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.